FINCH THERAPEUTICS GROUP, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.309 USD | +3.09% |
|
+0.40% | -36.03% |
| 03-25 | Finch Therapeutics Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-12 | Top Premarket Decliners | MT |
Chart calendar Finch Therapeutics Group, Inc.
2b657d2b12dacc840fe40b3417d80._ITAJU6rKRdfxniQP8HjXr6CEDNzoOUzGfLZO_PAsd0.mbWCUQrqe1IthUDpEpuVb8_zegQbmKtmaJ-WfrCDy5jK_bASCOEebieKLQ~9368858cff6cd74177a858576e5fa44a
Past events on Finch Therapeutics Group, Inc.
| 10/06/2023 15:30 | Annual General Meeting |
| 10/05/2023 12:00 | Q1 2023 Earnings Release |
| 23/03/2023 20:05 | Q4 2022 Earnings Release |
| 01/12/2022 16:20 | Evercore ISI HealthCONx Conference |
| 16/11/2022 10:55 | Jefferies London Healthcare Conference |
| 10/11/2022 12:00 | Q3 2022 Earnings Release |
| 11/08/2022 12:00 | Interim 2022 Earnings Release |
| 15/06/2022 19:00 | JMP Securities Life Sciences Conference |
| 10/06/2022 15:30 | Annual General Meeting |
| 10/06/2022 13:00 | Jefferies Healthcare Conference |
| 24/05/2022 12:00 | H.C. Wainwright Global Life Sciences Investment Conference |
| 16/05/2022 13:00 | Business Update Call |
| 16/05/2022 12:00 | Q1 2022 Earnings Release |
| 31/03/2022 21:56 | FY 2021 Earnings Release |
| 01/03/2022 20:15 | Chardan Metagenomics and Microbiome Medicines Summit - Panel |
| 13/01/2022 14:45 | JP Morgan Healthcare Conference |
| 10/01/2022 12:00 | H.C. Wainwright BioConnect Conference |
| 02/12/2021 15:05 | Evercore ISI HealthCONx Conference |
| 18/11/2021 08:00 | Jefferies London Healthcare Conference - Pre- Recorded |
| 10/11/2021 12:05 | Q3 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 7,72 | 18,5 20,2 -8.32% | 0,86 1,30 -33.77% |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -57,7 -77,3 25.39% | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -60,0 -67,0 10.41% | -95,1 -103 7.65% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -115 -104 -10.34% |
|
Net income Million USD | Released Forecast Spread | 0,00 | -58,2 -67,0 13.14% | -115 -104 -10.34% |
|
EPS USD | Released Forecast Spread | -9,90 | -44,4 -51,5 13.7% | -72,0 -66,9 -7.62% |
| Announcement Date | 26/02/21 | 31/03/22 | 23/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,81 5,00 -83.88% | 0,36 1,30 -72.23% | 0,14 1,50 -90.8% | 0,01 0,40 -98% | 0,11 0,00 - | 0,00 0,00 - | |
|
EBITDA Million USD | Released Forecast Spread | -20,4 -22,0 7.47% | ||||||
|
EBIT Million USD | Released Forecast Spread | -19,1 -15,0 -27.08% | -21,7 -19,9 -9.45% | -21,3 -18,9 -12.72% | -27,5 -15,2 -80.98% | -18,1 -4,10 -341.41% | -9,08 -7,30 -24.38% | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -22,7 -17,7 -28.25% | -40,4 -19,8 -103.89% | -27,0 -16,3 -65.69% | -67,4 -4,10 -1543.9% | -6,95 -7,30 4.79% | ||
|
Net income Million USD | Released Forecast Spread | -19,1 -15,0 -27.03% | -24,6 | -22,7 -19,9 -14.36% | -40,4 -18,9 -113.6% | -27,0 -16,3 -65.69% | -63,9 -4,10 -1459.49% | -6,95 -7,30 4.79% |
|
EPS USD | Released Forecast Spread | -12,0 -9,60 -25% | -15,6 | -14,4 -12,5 -15.66% | -25,5 -12,0 -112.5% | -16,8 -10,2 -64.71% | -39,9 -2,70 -1377.78% | -4,33 -4,50 3.78% |
| Announcement Date | 31/03/22 | 16/05/22 | 11/08/22 | 10/11/22 | 23/03/23 | 10/05/23 | 10/08/23 |
More events
Past sector events for Finch Therapeutics Group, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FNCH Stock
- Calendar Finch Therapeutics Group, Inc.
